RU99107277A - BICYCLIC AROMATIC COMPOUNDS AND THEIR APPLICATION IN MEDICINE AND VETERINARIA, AND ALSO IN COSMETOLOGY - Google Patents
BICYCLIC AROMATIC COMPOUNDS AND THEIR APPLICATION IN MEDICINE AND VETERINARIA, AND ALSO IN COSMETOLOGYInfo
- Publication number
- RU99107277A RU99107277A RU99107277/04A RU99107277A RU99107277A RU 99107277 A RU99107277 A RU 99107277A RU 99107277/04 A RU99107277/04 A RU 99107277/04A RU 99107277 A RU99107277 A RU 99107277A RU 99107277 A RU99107277 A RU 99107277A
- Authority
- RU
- Russia
- Prior art keywords
- radical
- tetrahydro
- naphthyl
- acrylic acid
- tetramethyl
- Prior art date
Links
- 150000001491 aromatic compounds Chemical class 0.000 title 1
- -1 alkyl radical Chemical class 0.000 claims 63
- 150000003254 radicals Chemical class 0.000 claims 58
- 150000001875 compounds Chemical class 0.000 claims 25
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 15
- 239000002253 acid Substances 0.000 claims 14
- 201000010099 disease Diseases 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 206010000496 Acne Diseases 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 239000004721 Polyphenylene oxide Substances 0.000 claims 5
- 125000004432 carbon atoms Chemical group C* 0.000 claims 5
- 229920000728 polyester Polymers 0.000 claims 5
- 229920000570 polyether Polymers 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 5
- 230000003780 keratinization Effects 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 210000003491 Skin Anatomy 0.000 claims 3
- 230000032683 aging Effects 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 3
- 206010021198 Ichthyosis Diseases 0.000 claims 2
- 206010021197 Ichthyosis Diseases 0.000 claims 2
- 208000006641 Skin Disease Diseases 0.000 claims 2
- 206010040799 Skin atrophy Diseases 0.000 claims 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl radical Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims 2
- 200000000018 inflammatory disease Diseases 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N oxygen atom Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 230000037390 scarring Effects 0.000 claims 2
- 201000010153 skin papilloma Diseases 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000004434 sulfur atoms Chemical group 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 230000003612 virological Effects 0.000 claims 2
- UUKKLXFZARDGTQ-UHFFFAOYSA-N 1-methoxy-1-methylperoxyethane Chemical compound COOC(C)OC UUKKLXFZARDGTQ-UHFFFAOYSA-N 0.000 claims 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol Chemical group OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims 1
- IIVWHGMLFGNMOW-UHFFFAOYSA-N 2-methylpropane Chemical compound C[C](C)C IIVWHGMLFGNMOW-UHFFFAOYSA-N 0.000 claims 1
- VGNMHOCPKJBHDX-UHFFFAOYSA-N 3-[3-(2-butoxy-3,5-ditert-butylphenyl)-4-hydroxyphenyl]prop-2-enoic acid Chemical compound C1=C(C(C)(C)C)C=C(C(C)(C)C)C(OCCCC)=C1C1=CC(C=CC(O)=O)=CC=C1O VGNMHOCPKJBHDX-UHFFFAOYSA-N 0.000 claims 1
- KEQNUDCJRHGSTI-UHFFFAOYSA-N 3-[3-(2-butoxy-3,5-ditert-butylphenyl)-4-methoxyphenyl]prop-2-enoic acid Chemical compound C1=C(C(C)(C)C)C=C(C(C)(C)C)C(OCCCC)=C1C1=CC(C=CC(O)=O)=CC=C1OC KEQNUDCJRHGSTI-UHFFFAOYSA-N 0.000 claims 1
- XIFDKCFCEMMJRC-UHFFFAOYSA-N 3-[3-(3,5-ditert-butyl-2-methoxyphenyl)-4-hydroxyphenyl]prop-2-enoic acid Chemical compound C1=C(C(C)(C)C)C=C(C(C)(C)C)C(OC)=C1C1=CC(C=CC(O)=O)=CC=C1O XIFDKCFCEMMJRC-UHFFFAOYSA-N 0.000 claims 1
- UVZTXJKXRTUSFF-UHFFFAOYSA-N 3-[3-(3,5-ditert-butyl-2-methoxyphenyl)phenyl]prop-2-enoic acid Chemical compound C1=C(C(C)(C)C)C=C(C(C)(C)C)C(OC)=C1C1=CC=CC(C=CC(O)=O)=C1 UVZTXJKXRTUSFF-UHFFFAOYSA-N 0.000 claims 1
- LJNIYAYZVBGBHA-UHFFFAOYSA-N 3-[3-(3,5-ditert-butyl-2-pentoxyphenyl)-4-hydroxyphenyl]prop-2-enoic acid Chemical compound C1=C(C(C)(C)C)C=C(C(C)(C)C)C(OCCCCC)=C1C1=CC(C=CC(O)=O)=CC=C1O LJNIYAYZVBGBHA-UHFFFAOYSA-N 0.000 claims 1
- TYCUPGDZNOYHCV-UHFFFAOYSA-N 3-[3-(3,5-ditert-butyl-2-phenylmethoxyphenyl)-4-hydroxyphenyl]prop-2-enoic acid Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(C=2C(=CC=C(C=CC(O)=O)C=2)O)=C1OCC1=CC=CC=C1 TYCUPGDZNOYHCV-UHFFFAOYSA-N 0.000 claims 1
- IZEVBECGYZTKOF-UHFFFAOYSA-N 3-[3-(3,5-ditert-butyl-2-propoxyphenyl)-4-hydroxyphenyl]prop-2-enoic acid Chemical compound C1=C(C(C)(C)C)C=C(C(C)(C)C)C(OCCC)=C1C1=CC(C=CC(O)=O)=CC=C1O IZEVBECGYZTKOF-UHFFFAOYSA-N 0.000 claims 1
- RSZLUTVLKZHSIV-UHFFFAOYSA-N 3-[3-(3,5-ditert-butyl-2-propoxyphenyl)-4-methoxyphenyl]prop-2-enoic acid Chemical compound C1=C(C(C)(C)C)C=C(C(C)(C)C)C(OCCC)=C1C1=CC(C=CC(O)=O)=CC=C1OC RSZLUTVLKZHSIV-UHFFFAOYSA-N 0.000 claims 1
- QKJTVDQLHLBJSP-UHFFFAOYSA-N 3-[3-(5,5,8,8-tetramethyl-1-phenylmethoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound C=1C=CC(C=CC(O)=O)=CC=1C1=CC=C2C(C)(C)CCC(C)(C)C2=C1OCC1=CC=CC=C1 QKJTVDQLHLBJSP-UHFFFAOYSA-N 0.000 claims 1
- JNKLAXMYIPUDCC-UHFFFAOYSA-N 3-[3-[3-(1-adamantyl)-4-hydroxyphenyl]phenyl]prop-2-enoic acid Chemical compound OC(=O)C=CC1=CC=CC(C=2C=C(C(O)=CC=2)C23CC4CC(CC(C4)C2)C3)=C1 JNKLAXMYIPUDCC-UHFFFAOYSA-N 0.000 claims 1
- DYQFSUPZVRLCIT-UHFFFAOYSA-N 3-[3-[3-(3-hydroxypropoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCO DYQFSUPZVRLCIT-UHFFFAOYSA-N 0.000 claims 1
- OPCROPNKKJNBNH-UHFFFAOYSA-N 3-[3-[3-(5-hydroxypentoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCO OPCROPNKKJNBNH-UHFFFAOYSA-N 0.000 claims 1
- HEIMAHPOPQCKNG-UHFFFAOYSA-N 3-[3-[3-(6-amino-6-oxohexoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCC(N)=O HEIMAHPOPQCKNG-UHFFFAOYSA-N 0.000 claims 1
- JXCXGGIUWRECKW-UHFFFAOYSA-N 3-[3-[3-(6-hydroxyhexoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCCO JXCXGGIUWRECKW-UHFFFAOYSA-N 0.000 claims 1
- DJZRERGRCLLLLP-UHFFFAOYSA-N 3-[3-[3-(7-hydroxyheptoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCCCO DJZRERGRCLLLLP-UHFFFAOYSA-N 0.000 claims 1
- YWRHRWGMTDYWQR-UHFFFAOYSA-N 3-[3-[3-(8-amino-8-oxooctoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCCCC(N)=O YWRHRWGMTDYWQR-UHFFFAOYSA-N 0.000 claims 1
- XGLGSXDJOBVYEY-UHFFFAOYSA-N 3-[3-[3-[(3-hydroxyphenyl)methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCC1=CC=CC(O)=C1 XGLGSXDJOBVYEY-UHFFFAOYSA-N 0.000 claims 1
- XDSUPVYJLPJXPK-UHFFFAOYSA-N 3-[3-[3-[(4-fluorophenyl)methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-4-hydroxyphenyl]prop-2-enoic acid Chemical compound C1=C2C(C)(C)CCC(C)(C)C2=CC(C=2C(=CC=C(C=CC(O)=O)C=2)O)=C1OCC1=CC=C(F)C=C1 XDSUPVYJLPJXPK-UHFFFAOYSA-N 0.000 claims 1
- GLSKPQMYWRIQRK-UHFFFAOYSA-N 3-[3-[5-(1-adamantyl)-4-methoxy-2-methylphenyl]-4-(methoxymethoxy)phenyl]prop-2-enoic acid Chemical compound COCOC1=CC=C(C=CC(O)=O)C=C1C1=CC(C23CC4CC(CC(C4)C2)C3)=C(OC)C=C1C GLSKPQMYWRIQRK-UHFFFAOYSA-N 0.000 claims 1
- MTBYYEVKTRHVAO-UHFFFAOYSA-N 3-[3-[5-(1-adamantyl)-4-methoxy-2-methylphenyl]-4-hydroxyphenyl]prop-2-enoic acid Chemical compound C1=C(C23CC4CC(CC(C4)C2)C3)C(OC)=CC(C)=C1C1=CC(C=CC(O)=O)=CC=C1O MTBYYEVKTRHVAO-UHFFFAOYSA-N 0.000 claims 1
- NRVSLABAAWAZPW-UHFFFAOYSA-N 3-[3-[5-(1-adamantyl)-4-methoxy-2-methylphenyl]phenyl]prop-2-enoic acid Chemical compound C1=C(C23CC4CC(CC(C4)C2)C3)C(OC)=CC(C)=C1C1=CC=CC(C=CC(O)=O)=C1 NRVSLABAAWAZPW-UHFFFAOYSA-N 0.000 claims 1
- NUTKUKZDAAEPIU-UHFFFAOYSA-N 3-[4-(methoxymethoxy)-3-(5,5,8,8-tetramethyl-3-pentoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound CCCCCOC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1OCOC NUTKUKZDAAEPIU-UHFFFAOYSA-N 0.000 claims 1
- IZFPAKFFQQPROO-UHFFFAOYSA-N 3-[4-(methoxymethoxy)-3-(5,5,8,8-tetramethyl-3-phenylmethoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound COCOC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCC1=CC=CC=C1 IZFPAKFFQQPROO-UHFFFAOYSA-N 0.000 claims 1
- AKLQOWZLWPAQOB-UHFFFAOYSA-N 3-[4-(methoxymethoxy)-3-(5,5,8,8-tetramethyl-3-propoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound CCCOC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1OCOC AKLQOWZLWPAQOB-UHFFFAOYSA-N 0.000 claims 1
- YGGDMEZKJDDBPM-UHFFFAOYSA-N 3-[4-fluoro-3-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound CC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1F YGGDMEZKJDDBPM-UHFFFAOYSA-N 0.000 claims 1
- HLCZHYDMWHIDQS-UHFFFAOYSA-N 3-[4-hydroxy-3-(5,5,8,8-tetramethyl-3-phenylmethoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound C1=C2C(C)(C)CCC(C)(C)C2=CC(C=2C(=CC=C(C=CC(O)=O)C=2)O)=C1OCC1=CC=CC=C1 HLCZHYDMWHIDQS-UHFFFAOYSA-N 0.000 claims 1
- LCBKSLYILFCQKT-UHFFFAOYSA-N 3-[4-hydroxy-3-(5,5,8,8-tetramethyl-4-propoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound C=1C(C(CCC2(C)C)(C)C)=C2C(OCCC)=CC=1C1=CC(C=CC(O)=O)=CC=C1O LCBKSLYILFCQKT-UHFFFAOYSA-N 0.000 claims 1
- PUYPAEVRAZEYDX-UHFFFAOYSA-N 3-[4-hydroxy-3-[3-(methoxymethoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound COCOC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1O PUYPAEVRAZEYDX-UHFFFAOYSA-N 0.000 claims 1
- MVKDVTQMAADJKF-UHFFFAOYSA-N 3-[4-hydroxy-3-[3-[(3-methoxyphenyl)methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound COC1=CC=CC(COC=2C(=CC3=C(C(CCC3(C)C)(C)C)C=2)C=2C(=CC=C(C=CC(O)=O)C=2)O)=C1 MVKDVTQMAADJKF-UHFFFAOYSA-N 0.000 claims 1
- GIRHLHPFKPJQNE-UHFFFAOYSA-N 3-[4-hydroxy-3-[3-[(4-methoxyphenyl)methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound C1=CC(OC)=CC=C1COC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1O GIRHLHPFKPJQNE-UHFFFAOYSA-N 0.000 claims 1
- WTRJCBZKNHXIPR-UHFFFAOYSA-N 3-[4-methoxy-3-(5,5,8,8-tetramethyl-3-phenylmethoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-en-1-ol Chemical compound COC1=CC=C(C=CCO)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCC1=CC=CC=C1 WTRJCBZKNHXIPR-UHFFFAOYSA-N 0.000 claims 1
- CZXDLWWQMMCRLH-UHFFFAOYSA-N 3-[4-methoxy-3-(5,5,8,8-tetramethyl-3-phenylmethoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enal Chemical compound COC1=CC=C(C=CC=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCC1=CC=CC=C1 CZXDLWWQMMCRLH-UHFFFAOYSA-N 0.000 claims 1
- GBYWCXMTZGABMB-UHFFFAOYSA-N 3-[4-methoxy-3-(5,5,8,8-tetramethyl-3-phenylmethoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCC1=CC=CC=C1 GBYWCXMTZGABMB-UHFFFAOYSA-N 0.000 claims 1
- FDJJTVNEQUVWCY-UHFFFAOYSA-N 3-[4-methoxy-3-[3-[(3-methoxyphenyl)methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound COC1=CC=CC(COC=2C(=CC3=C(C(CCC3(C)C)(C)C)C=2)C=2C(=CC=C(C=CC(O)=O)C=2)OC)=C1 FDJJTVNEQUVWCY-UHFFFAOYSA-N 0.000 claims 1
- DMZYXKPIRBFBNF-UHFFFAOYSA-N 3-[4-methoxy-3-[3-[(4-methoxyphenyl)methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound C1=CC(OC)=CC=C1COC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1OC DMZYXKPIRBFBNF-UHFFFAOYSA-N 0.000 claims 1
- HMYQFWHFRUAVDB-UHFFFAOYSA-N 3-[4-methoxy-3-[3-[[2-(methoxymethoxy)phenyl]methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound COCOC1=CC=CC=C1COC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1OC HMYQFWHFRUAVDB-UHFFFAOYSA-N 0.000 claims 1
- CYQSLRFABJXHMY-UHFFFAOYSA-N 3-[4-methoxy-3-[3-[[3-(methoxymethoxy)phenyl]methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound COCOC1=CC=CC(COC=2C(=CC3=C(C(CCC3(C)C)(C)C)C=2)C=2C(=CC=C(C=CC(O)=O)C=2)OC)=C1 CYQSLRFABJXHMY-UHFFFAOYSA-N 0.000 claims 1
- XKZKOVVUVUQUPV-UHFFFAOYSA-N 3-[4-methoxy-3-[3-[[4-(methoxymethoxy)phenyl]methoxy]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound C1=CC(OCOC)=CC=C1COC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1=CC(C=CC(O)=O)=CC=C1OC XKZKOVVUVUQUPV-UHFFFAOYSA-N 0.000 claims 1
- XDBJGBUIFLUEPN-UHFFFAOYSA-N 3-[4-methoxy-3-[5,5,8,8-tetramethyl-3-[6-[(2-methylpropan-2-yl)oxy]-6-oxohexoxy]-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCC(=O)OC(C)(C)C XDBJGBUIFLUEPN-UHFFFAOYSA-N 0.000 claims 1
- COLUBWDKWAQUPQ-UHFFFAOYSA-N 3-[4-methoxy-3-[5,5,8,8-tetramethyl-3-[8-[(2-methylpropan-2-yl)oxy]-8-oxooctoxy]-6,7-dihydronaphthalen-2-yl]phenyl]prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCCCC(=O)OC(C)(C)C COLUBWDKWAQUPQ-UHFFFAOYSA-N 0.000 claims 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- FXKCDDRGYFBEFK-UHFFFAOYSA-N 6-[[3-[5-(2-carboxyethenyl)-2-methoxyphenyl]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]oxy]hexanoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCC(O)=O FXKCDDRGYFBEFK-UHFFFAOYSA-N 0.000 claims 1
- BNGSZTMRHOOXLS-UHFFFAOYSA-N 8-[[3-[5-(2-carboxyethenyl)-2-methoxyphenyl]-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]oxy]octanoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1C1=CC(C(CCC2(C)C)(C)C)=C2C=C1OCCCCCCCC(O)=O BNGSZTMRHOOXLS-UHFFFAOYSA-N 0.000 claims 1
- 208000009621 Actinic Keratosis Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 206010003246 Arthritis Diseases 0.000 claims 1
- 206010003645 Atopy Diseases 0.000 claims 1
- KRSDSSXXUWOYKD-UHFFFAOYSA-N C12(CC3CC(CC(C1)C3)C2)C=1C(=CC(=C(C=1)C1=CC(=CC=C1)C=CC(=CC)C)C)OC Chemical compound C12(CC3CC(CC(C1)C3)C2)C=1C(=CC(=C(C=1)C1=CC(=CC=C1)C=CC(=CC)C)C)OC KRSDSSXXUWOYKD-UHFFFAOYSA-N 0.000 claims 1
- PHWSQIHMLSFJMM-UHFFFAOYSA-N CC(=CC)C=CC1=CC(=CC=C1)C1=CC=2C(CCC(C=2C=C1C)(C)C)(C)C Chemical compound CC(=CC)C=CC1=CC(=CC=C1)C1=CC=2C(CCC(C=2C=C1C)(C)C)(C)C PHWSQIHMLSFJMM-UHFFFAOYSA-N 0.000 claims 1
- OCVLAZAVBZJGGZ-UHFFFAOYSA-N CC=1C(=CC=2C(CCC(C=2C=1)(C)C)(C)C)C=1C=C(C=CC=1)C(C=CC)=C Chemical compound CC=1C(=CC=2C(CCC(C=2C=1)(C)C)(C)C)C=1C=C(C=CC=1)C(C=CC)=C OCVLAZAVBZJGGZ-UHFFFAOYSA-N 0.000 claims 1
- 208000008006 Collagen Disease Diseases 0.000 claims 1
- 229940064701 Corticosteroid nasal preparations for topical use Drugs 0.000 claims 1
- 229960001334 Corticosteroids Drugs 0.000 claims 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 208000005679 Eczema Diseases 0.000 claims 1
- 210000000981 Epithelium Anatomy 0.000 claims 1
- 208000009197 Gingival Hypertrophy Diseases 0.000 claims 1
- 210000000224 Granular leucocyte Anatomy 0.000 claims 1
- 206010020649 Hyperkeratosis Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 206010024324 Leukaemias Diseases 0.000 claims 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N Methyl radical Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims 1
- 206010028703 Nail psoriasis Diseases 0.000 claims 1
- 210000000440 Neutrophils Anatomy 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000001254 Occupational Disease Diseases 0.000 claims 1
- 208000003154 Papilloma Diseases 0.000 claims 1
- 206010062080 Pigmentation disease Diseases 0.000 claims 1
- 208000006994 Precancerous Condition Diseases 0.000 claims 1
- 206010072736 Rheumatic disease Diseases 0.000 claims 1
- 206010039580 Scar Diseases 0.000 claims 1
- 210000001732 Sebaceous Glands Anatomy 0.000 claims 1
- 208000008742 Seborrheic Dermatitis Diseases 0.000 claims 1
- 206010039792 Seborrhoea Diseases 0.000 claims 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 201000004384 alopecia Diseases 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 150000001509 aspartic acid derivatives Chemical class 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 210000000748 cardiovascular system Anatomy 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 230000001419 dependent Effects 0.000 claims 1
- 201000004624 dermatitis Diseases 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- SRXOCFMDUSFFAK-UHFFFAOYSA-N dimethyl peroxide Chemical compound COOC SRXOCFMDUSFFAK-UHFFFAOYSA-N 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 231100001003 eczema Toxicity 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 150000002332 glycine derivatives Chemical class 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 150000002668 lysine derivatives Chemical class 0.000 claims 1
- 230000003211 malignant Effects 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000003287 optical Effects 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000019612 pigmentation Effects 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 230000001185 psoriatic Effects 0.000 claims 1
- 230000000241 respiratory Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 231100000241 scar Toxicity 0.000 claims 1
- 230000037387 scars Effects 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 229940083878 topical for treatment of hemorrhoids and anal fissures Corticosteroids Drugs 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical group O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 claims 1
Claims (23)
в которой R1 представляет i) радикал -СН3, ii) радикал -CH2OR2, iii) радикал -СО-R3,
R2 и R3 имеют значения, приведенные ниже,
Ar1 представляет радикал, выбранный из радикалов формул (а)-(с) ниже:
R4, R5, R6, R7, R8, R9, R10 и R11 имеют значения, приведенные ниже,
Ar2 представляет радикал, выбранный из радикалов формул (d)-(h) ниже:
R12 и R13 имеют значения, приведенные ниже,
Х представляет радикал, выбранный из радикалов формул (i)-(l),
R14, R15 и Y имеют значения, приведенные ниже,
R2 представляет атом водорода, низший алкил или CO-R16,
R16 имеет значения, приведенные ниже,
R3 представляет (а) атом водорода, (b) радикал низший алкил, (с) радикал с формулой:
R' и R'' имеют значения, приведенные ниже, (d) радикал -OR17,
R17 имеет значения, приведенные ниже,
R4 представляет атом водорода, полиэфирный радикал, радикал низший алкил или радикал OR18,
R18 имеет значения, приведенные ниже,
R5 представляет атом водорода, радикал низший алкил, полиэфирный радикал или радикал OR19,
R19 имеет значения, приведенные ниже,
R6 представляет радикал трет-бутил,
R7 представляет радикал низший алкил, полиэфирный радикал или радикал OR20,
R20 имеет значения, приведенные ниже,
R6 и R7, взятые вместе, могут образовать со смежным ароматическим кольцом, 6-членное кольцо, необязательно замещенное метильными группами и/или необязательно прерывающееся атомом кислорода или серы,
R8 представляет радикал трет-бутил, адамантил, арил или аралкил,
R9 и R10, взятые вместе, образуют со смежным ароматическим кольцом, 5- или 6-членное кольцо, необязательно замещенное метильными группами и/или необязательно прерывающееся атомом кислорода или серы,
R11 представляет атом водорода, радикал низший алкил, содержащий от 1 до 9 атомов углерода, радикал гидроксил, радикал алкокси, полиэфирный радикал или радикал -OR21,
R21 имеет значения, приведенные ниже,
R12 представляет атом водорода, радикал гидроксил, радикал алкокси, полиэфирный радикал или радикал -OR22,
R22 имеет значения, приведенные ниже,
R13 представляет атом водорода, радикал низший алкил или радикал -СОR23,
R23 имеет значения, приведенные ниже,
R14 и R15, которые могут быть одинаковыми или различными, представляют атом водорода или радикал низший алкил,
Y представляет атом кислорода или радикал СН2,
R16 представляет радикал низший алкил,
R17 представляет атом водорода, нормальный или разветвленный радикал алкил, содержащий от 1 до 20 атомов углерода, радикал алкенил, радикал моно- или полигидроксиалкил, необязательно замещенный радикал арил или аралкил или остаток сахара,
R' или R'', которые могут быть одинаковыми или различными, представляют атом водорода, радикал низший алкил, радикал моно- или полигидроксиалкил, необязательно замещенный радикал арил или остаток аминокислоты, или, альтернативно, взятые вместе, образуют гетероцикл,
R18, R19 и R20, которые могут быть одинаковыми или различными, представляют атом водорода, радикал низший алкил, радикал алкенил, радикал моно- или полигидроксиалкил, радикал арил, необязательно замещенный радикал аралкил или радикал -(СН2)n-R24,
n и R24 имеют значения, приведенные ниже,
R21 и R22, которые могут быть одинаковыми или различными, представляют радикал алкенил, радикал моно- или полигидроксиалкил, радикал арил, необязательно замещенный радикал аралкил или радикал -(CH2)n-R24,
n и R24 имеют значения, приведенные ниже,
R23 представляет радикал низший алкил,
R24 представляет гетероцикл, радикал моногидроксиалкил, радикал тиол, необязательно замещенный низшим алкилом, аминогруппа, необязательно замещенная по меньшей мере одним низшим алкилом, радикал -COOR25 или радикал -CON(R24)R27,
R25, R26 и R27 имеют значения, приведенные ниже,
R25 представляет атом водорода или радикал низший алкил,
R26 и R27 являются одинаковыми или различными и представляют атом водорода, радикал низший алкил или необязательно замещенный радикал арил или, взятые вместе, образуют гетероцикл,
n является целым числом, таким, что 2 ≅ n ≅ 9,
при условии, что:
когда Ar1 представляет радикал формулы (с) и Х представляет радикалы формулы (i) или (j), тогда
R11 представляет радикал -OR21 или полиэфирный радикал или
Ar2 представляет радикал формулы (d), где R12 представляет радикал -OR22 или полиэфирный радикал,
соединения формулы (I) отличаются от таких, где
R11 представляет радикал метоксиметокси в орто-положении по отношению к заместителю Аr2, когда Ar1 представляет радикал формулы (с), Х представляет радикал формулы (i), R12 представляет водород и R1 представляет радикал СОR3, где R3 представляет радикал -OR17 и R17 представляет водород,
R12 представляет радикал метоксиметокси в орто- или пара-положении по отношению к заместителю Ar1, когда Ar1 представляет радикал формулы (с), Х представляет радикал формулы (i), R11 представляет радикал метил в орто-положении по отношению к Ar2, R1 представляет радикал COR3, где R3 представляет радикал -OR17, и R17 представляет водород, и оптические и геометрические изомеры, указанных соединений формулы (I), а также их соли.1. Compounds characterized in that they correspond to the general formula (I) below:
in which R 1 is i) the radical —CH 3 , ii) the radical —CH 2 OR 2 , iii) the radical —CO — R 3 ,
R 2 and R 3 have the meanings given below.
Ar 1 represents a radical selected from the radicals of the formulas (a) - (c) below:
R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 have the meanings given below.
Ar 2 represents a radical selected from the radicals of the formulas (d) - (h) below:
R 12 and R 13 have the meanings given below.
X represents a radical selected from the radicals of the formulas (i) - (l),
R 14 , R 15 and Y have the meanings given below.
R 2 represents a hydrogen atom, lower alkyl or CO-R 16 ,
R 16 is as defined below.
R 3 represents (a) a hydrogen atom, (b) a lower alkyl radical, (c) a radical with the formula:
R 'and R "have the meanings given below, (d) the radical -OR 17 ,
R 17 has the meanings given below.
R 4 represents a hydrogen atom, a polyester radical, a lower alkyl radical or an OR 18 radical,
R 18 has the meanings given below.
R 5 represents a hydrogen atom, a lower alkyl radical, a polyether radical or an OR 19 radical,
R 19 has the meanings given below.
R 6 is a tert-butyl radical,
R 7 represents a lower alkyl radical, a polyester radical or an OR 20 radical,
R 20 has the meanings given below.
R 6 and R 7 , taken together, can form with an adjacent aromatic ring, a 6-membered ring, optionally substituted by methyl groups and / or optionally interrupted by an oxygen or sulfur atom,
R 8 represents a radical tert-butyl, adamantyl, aryl or aralkyl,
R 9 and R 10 , taken together, form with an adjacent aromatic ring, a 5- or 6-membered ring, optionally substituted by methyl groups and / or optionally interrupted by an oxygen or sulfur atom,
R 11 represents a hydrogen atom, a lower alkyl radical containing from 1 to 9 carbon atoms, a hydroxyl radical, an alkoxy radical, a polyether radical or an -OR 21 radical,
R 21 has the meanings given below.
R 12 represents a hydrogen atom, a hydroxyl radical, an alkoxy radical, a polyether radical or an —OR 22 radical,
R 22 has the meanings given below.
R 13 represents a hydrogen atom, a lower alkyl radical or a —OR 23 radical,
R 23 matter below
R 14 and R 15 , which may be the same or different, represent a hydrogen atom or a lower alkyl radical,
Y represents an oxygen atom or a CH 2 radical,
R 16 represents a lower alkyl radical,
R 17 represents a hydrogen atom, a normal or branched alkyl radical containing from 1 to 20 carbon atoms, an alkenyl radical, a mono- or polyhydroxyalkyl radical, an optionally substituted aryl or aralkyl radical, or a sugar residue,
R ′ or R ″, which may be the same or different, represent a hydrogen atom, a lower alkyl radical, a mono- or polyhydroxyalkyl radical, an optionally substituted aryl radical, or an amino acid residue, or, alternatively, taken together form a heterocycle,
R 18 , R 19 and R 20 , which may be the same or different, represent a hydrogen atom, a lower alkyl radical, an alkenyl radical, a mono- or polyhydroxyalkyl radical, an aryl radical, an optionally substituted aralkyl radical, or a - (CH 2 ) n -R radical 24 ,
n and R 24 have the meanings given below.
R 21 and R 22 , which may be the same or different, represent an alkenyl radical, a mono- or polyhydroxyalkyl radical, an aryl radical, an optionally substituted aralkyl radical, or a - (CH 2 ) n -R 24 radical,
n and R 24 have the meanings given below.
R 23 represents a lower alkyl radical,
R 24 is a heterocycle, a monohydroxyalkyl radical, a thiol radical, optionally substituted by lower alkyl, an amino group, optionally substituted by at least one lower alkyl, a —COOR 25 radical, or a —CON (R 24 ) R 27 radical,
R 25 , R 26 and R 27 have the meanings given below.
R 25 represents a hydrogen atom or a lower alkyl radical,
R 26 and R 27 are the same or different and represent a hydrogen atom, a lower alkyl radical or an optionally substituted aryl radical, or taken together form a heterocycle,
n is an integer such that 2 ≅ n ≅ 9,
provided that:
when Ar 1 represents a radical of formula (c) and X represents a radical of formula (i) or (j), then
R 11 represents an —OR 21 radical or a polyester radical or
Ar 2 represents a radical of the formula (d), where R 12 represents an —OR 22 radical or a polyether radical,
the compounds of formula (I) differ from those where
R 11 represents an methoxymethoxy radical in the ortho-position with respect to the substituent Ar 2 when Ar 1 represents a radical of formula (c), X represents a radical of formula (i), R 12 represents hydrogen and R 1 represents a COR 3 radical, where R 3 represents the radical —OR 17 and R 17 represents hydrogen,
R 12 represents a methoxymethoxy radical in the ortho or para position with respect to the substituent Ar 1 , when Ar 1 represents a radical of formula (c), X represents a radical of formula (i), R 11 represents a methyl radical in the ortho position with respect to Ar 2 , R 1 represents a COR 3 radical, where R 3 represents an -OR 17 radical, and R 17 represents hydrogen, and optical and geometric isomers, of the indicated compounds of formula (I), as well as their salts.
3-(3',5'-дитрет-бутил-2'-метокси-3-бифенилил)акриловую кислоту,
3-(2'-бензилокси-3',5'-дитрет-бутил-6-гидрокси-3-бифенилил)акриловую кислоту,
3-(3',5'-дитрет-бутил-6-гидрокси-2'-пентилокси-3-бифенилил)акриловую кислоту,
3-(3',5'-дитрет-бутил-6-гидрокси-2'-метокси-3-бифенилил)акриловую кислоту,
3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)-4-метоксиметоксифенил]акриловую кислоту,
3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)-4-гидроксифенил]акриловую кислоту,
[4-метоксиметокси-(3,5,5,8,8-пентаметил-5,6,7,8-тетрагидро-2-нафтил)фенил]пропионовую кислоту,
3-[3-(3-пропилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)-4-метоксиметоксифенил]акриловую кислоту,
3-[3-(3-пентилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидpo-2-нaфтил)-4-мeтoкcимeтoкcифeнил]акpилoвую кислоту,
3-(5'-адамантан-1-ил-4'-метокси-2'-метил-3-бифенилил)акриловую кислоту,
3-(5'-адамантан-1-ил-6-гидрокси-4'-метокси-2'-метил-3-бифенилил)акриловую кислоту,
3-(5'-адамантан-1-ил-4'-метокси-6-метоксиметокси-2'-метил-3-бифенилил)акриловую кислоту,
3-{ 4-метокси-3-[3-(3-метоксибензилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]фенил}акриловую кислоту,
3-{ 4-метокси-3-[3-(4-метоксибензилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]фенил}акриловую кислоту,
3-{ 3-[3-(6-гидроксигексилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]-4-метоксифенил}акриловую кислоту,
3-{ 3-[3-(7-гидроксигептилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]-4-метоксифенил}акриловую кислоту,
3-{ 3-[3-(5-гидроксипентилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]-4-метоксифенил}акриловую кислоту,
3-{ 3-[3-(3-гидроксипропилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]-4-метоксифенил}акриловую кислоту,
3-[3-(1-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)фенил] акриловую кислоту,
3-(3'-адамантан-1-ил-4'-гидрокси-3-бифенилил) акриловую кислоту,
5-[4-метокси-3-(5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)фенил] -3-метилпента-2,4-диеновую кислоту,
5-[4-метоксиметокси-3-(5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)фенил]-3-метилпента-2,4-диеновую кислоту,
5-[4-гидрокси-3-(5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)фенил] -3-метилпента-2,4-диеновую кислоту,
3-{ 3-[3-(5-трет-бутоксикарбонилпентилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил] -4-метоксифенил} акриловую кислоту,
3-{ 3-[3-(7-трет-бутоксикарбонилгептилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]-4-метоксифенил} акриловую кислоту,
3-{ 3-[3-(7-карбоксигептилокси) -5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил] -4-метоксифенил} акриловую кислоту,
3-{ 3-[3-(5-карбоксипентилокси) -5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил] -4-метоксифенил} акриловую кислоту,
3-{ 3-[3-(5-карбамоилпентилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил] -4-метоксифенил} акриловую кислоту,
3-{3-[3-(7-карбамоилгептилокси) -5, 5, 8, 8-тетраметил-5, 6,7,8-тетрагидро-2-нафтил]-4-метоксифенил}акриловую кислоту,
3-{ 4-метокси-3- [5, 5, 8, 8-тетраметил-3- (2-морфолин-4-илэтокси) -5,6,7,8-тетрагидро-2-нафтил] фенил} акриловую кислоту,
3-{ 4-метокси-3- [5, 5, 8, 8-тетраметил-3- (2-пиперидин-1-илэтокси) -5,6,7,8-тетрагидро-2-нафтил] фенил} акриловую кислоту,
3-{ 4-метокси-3- [3- (2-метоксиметоксибензилокси) -5, 5, 8, 8-тетраметил-5, 6,7,8-тетрагидро-2-нафтил] фенил} акриловую кислоту,
3-{ 4-метокси-3-[3- (3-метоксиметоксибензилокси) -5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил] фенил} акриловую кислоту,
3-{ 4-метокси-3-[3-(4-метоксиметоксибензилокси) -5,5,8,8-тетраметил-5, 6,7,8-тетрагидро-2-нафтил] фенил} акриловую кислоту,
3-{ 4-метокси-3-[3-(3-гидроксибензилокси)-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил]фенил}акриловую кислоту,
3-[4-фтор-3-(3,5,5,8,8-пентаметил-5,6,7,8-тетрагидро- 2-нафтил) фенил] акриловую кислоту,
3-{ 4-гидрокси-3-[3-(3-метоксибензилокси) -5,5,8,8-тетраметил-5, 6, 7, 8-тетрагидро-2-нафтил] фенил}акриловую кислоту,
3-{ 4-гидрокси-3-[3-(4-метоксибензилокси) -5,5,8,8-тетраметил-5, 6,7, 8-тетрагидро-2-нафтил] фенил}акриловую кислоту,
3-{ 4-гидрокси-3-[3- (4-фторбензилокси) -5,5,8, 8-тетраметил-5, 6, 7, 8-тетрагидро-2-нафтил] фенил}акриловую кислоту,
3-{ 4-гидрокси-3- [3- (4-хлорбенэилокси) -5, 5, 8, 8-тетраметил-5, 6, 7, 8-тетрагидро-2-нафтил] фенил}акриловую кислоту,
3- [4-гидрокси-3- (3-метоксиметокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)фенил] акриловую кислоту,
3-(3', 5'-дитрет-бутил-6-гидрокси-2'-пропилокси-3-бифенилил)акриловую кислоту,
3- (3', 5'-дитрет-бутил-6-гидрокси-2'-бутилокси-3-бифенилил) акриловую кислоту,
3- (2'-бутокси-3',5'-дитрет-бутил-6-метокси-3-бифенилил) акриловую кислоту,
3-(3', 5'-дитрет-бутил-6-метокси-2'-пропокси-3-бифенилил) акриловую кислоту,
3-[4-гидрокси-3-(5,5,8,8-тетраметил-4-пропокси-5,6,7,8-тетрагидро-2-нафтил) фенил] акриловую кислоту,
3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)-4-метоксифенил]акриловую кислоту,
этил 3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8- тетрагидро-2-нафтил)-4-метоксифенил]акрилат,
3-метил-5-[3-(3,5,5,8,8-пентаметил-5,6,7,8-тетрагидро-2-нафтил)фенил] пента-2,4-диеновую кислоту,
3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)-4-метоксифенил]проп-2-ен-1-ол,
3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)-4-метоксифенил]пропеналь,
N-этил-3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тeтpaгидpo-2-нaфтил)-4-метоксифенил]акриламид,
3-[3-(3-бензилокси-5,5,8,8-тетраметил-5,6,7,8-тетрагидро-2-нафтил)-4-метоксифенил]-1-морфолин-4-ил-пропенон,
N-(4-гидроксифенил)-3-[3-(3-бензилокси-5,5,8,8-тетраметил-5, 6,7,8-тетрагидро-2-нафтил) -4-метоксифенил] акриламид,
5-(5'-адамантан-1-ил-4'-метокси-2'-метил-3-бифенилил)-3-метилпента-2,4-диеновую кислоту,
5-[4-метоксиметокси-3-(3,5,5,8,8-пентаметил-5,6,7,8-тетрагидро-2-нафтил)фенил]-3-метилпента-2,4-диеновую кислоту,
5-[4-гидрокси-3-(3,5,5,8,8-пентаметил-5,6,7,8-тетрагидро-2-нафтил)фенил] -3-метилпента-2,4-диеновую кислоту,
4-[3-(3,5,5,8,8-пентаметил-5,6,7,8-тетрагидро-2-нафтил) фенил] пента-2,4-диеновую кислоту,
5- (3',5'-дитрет-бутил-2'-метокси-3-бифенилил)-3-метилпента-2,4-диеновую кислоту,
5- (3', 5'-дитрет-бутил-2'-пропокси-3-бифенилил)-3-метилпента-2,4-диеновую кислоту,
5-(2'-бутокси-3', 5'-дитрет-бутил-3-бифенилил)-3-метилпента-2,4-диеновую кислоту,
5-(2'-бутокси-3', 5'-дитрет-бутил-6-гидрокси-3-бифенилил)-3-метилпента-2,4-диеновую кислоту,
5-(3', 5'-дитрет-бутил-6-гидрокси-2'-пропокси-3-бифенилил)-3-метилпента-2,4-диеновую кислоту,
5-(3', 5'-дитрет-бутил-6-гидрокси-2'-метокси-3-бифенилил)-3-метилпента-2,4-диеновую кислоту.15. Compounds of one of the preceding paragraphs, characterized in that they are selected from the group including:
3- (3 ', 5'-ditert-butyl-2'-methoxy-3-biphenylyl) acrylic acid,
3- (2'-benzyloxy-3 ', 5'-di-tert-butyl-6-hydroxy-3-biphenylyl) acrylic acid,
3- (3 ', 5'-ditert-butyl-6-hydroxy-2'-pentyloxy-3-biphenylyl) acrylic acid,
3- (3 ', 5'-di-tert-butyl-6-hydroxy-2'-methoxy-3-biphenylyl) acrylic acid,
3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxymethoxyphenyl] acrylic acid,
3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-hydroxyphenyl] acrylic acid,
[4-methoxymethoxy- (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] propionic acid,
3- [3- (3-propyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxymethoxyphenyl] acrylic acid,
3- [3- (3-pentyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxymethoxyphenyl] acrylic acid,
3- (5'-adamantan-1-yl-4'-methoxy-2'-methyl-3-biphenylyl) acrylic acid,
3- (5'-adamantan-1-yl-6-hydroxy-4'-methoxy-2'-methyl-3-biphenylyl) acrylic acid,
3- (5'-adamantan-1-yl-4'-methoxy-6-methoxymethoxy-2'-methyl-3-biphenylyl) acrylic acid,
3- {4-methoxy-3- [3- (3-methoxybenzyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {4-methoxy-3- [3- (4-methoxybenzyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {3- [3- (6-hydroxyhexyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (7-hydroxyheptyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (5-hydroxypentyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (3-hydroxypropyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- [3- (1-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] acrylic acid,
3- (3'-adamantan-1-yl-4'-hydroxy-3-biphenylyl) acrylic acid,
5- [4-methoxy-3- (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] -3-methylpent-2,4-diene acid,
5- [4-methoxymethoxy-3- (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] -3-methylpent-2,4-diene acid,
5- [4-hydroxy-3- (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] -3-methylpent-2,4-diene acid,
3- {3- [3- (5-tert-butoxycarbonylpentyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (7-tert-butoxycarbonylheptyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (7-carboxyheptyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (5-carboxypentyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (5-carbamoylpentyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {3- [3- (7-carbamoylheptyloxy) -5, 5, 8, 8-tetramethyl-5, 6,7,8-tetrahydro-2-naphthyl] -4-methoxyphenyl} acrylic acid,
3- {4-methoxy-3- [5, 5, 8, 8-tetramethyl-3- (2-morpholin-4-yletoxy) -5,6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid ,
3- {4-methoxy-3- [5, 5, 8, 8-tetramethyl-3- (2-piperidin-1-yletoxy) -5,6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid ,
3- {4-methoxy-3- [3- (2-methoxymethoxybenzyloxy) -5, 5, 8, 8-tetramethyl-5, 6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {4-methoxy-3- [3- (3-methoxymethoxybenzyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {4-methoxy-3- [3- (4-methoxymethoxybenzyloxy) -5,5,8,8-tetramethyl-5, 6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {4-methoxy-3- [3- (3-hydroxybenzyloxy) -5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- [4-fluoro-3- (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] acrylic acid,
3- {4-hydroxy-3- [3- (3-methoxybenzyloxy) -5,5,8,8-tetramethyl-5, 6, 7, 8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {4-hydroxy-3- [3- (4-methoxybenzyloxy) -5,5,8,8-tetramethyl-5, 6,7, 8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {4-hydroxy-3- [3- (4-fluorobenzyloxy) -5,5,8, 8-tetramethyl-5, 6, 7, 8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- {4-hydroxy-3- [3- (4-chlorobenoyloxy) -5, 5, 8, 8-tetramethyl-5, 6, 7, 8-tetrahydro-2-naphthyl] phenyl} acrylic acid,
3- [4-hydroxy-3- (3-methoxymethoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] acrylic acid,
3- (3 ', 5'-ditert-butyl-6-hydroxy-2'-propyloxy-3-biphenylyl) acrylic acid,
3- (3 ', 5'-ditert-butyl-6-hydroxy-2'-butyloxy-3-biphenylyl) acrylic acid,
3- (2'-butoxy-3 ', 5'-di-tert-butyl-6-methoxy-3-biphenylyl) acrylic acid,
3- (3 ', 5'-di-tert-butyl-6-methoxy-2'-propoxy-3-biphenylyl) acrylic acid,
3- [4-hydroxy-3- (5,5,8,8-tetramethyl-4-propoxy-5,6,7,8-tetrahydro-2-naphthyl) phenyl] acrylic acid,
3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxyphenyl] acrylic acid,
ethyl 3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxyphenyl] acrylate,
3-methyl-5- [3- (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] penta-2,4-diene acid,
3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxyphenyl] prop-2-en-1-ol,
3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxyphenyl] propenal,
N-ethyl-3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxyphenyl] acrylamide,
3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) -4-methoxyphenyl] -1-morpholin-4-yl-propenone,
N- (4-hydroxyphenyl) -3- [3- (3-benzyloxy-5,5,8,8-tetramethyl-5, 6,7,8-tetrahydro-2-naphthyl) -4-methoxyphenyl] acrylamide,
5- (5'-adamantan-1-yl-4'-methoxy-2'-methyl-3-biphenylyl) -3-methylpent-2,4-diene acid,
5- [4-methoxymethoxy-3- (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] -3-methylpent-2,4-diene acid,
5- [4-hydroxy-3- (3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] -3-methylpent-2,4-diene acid,
4- [3- (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl) phenyl] penta-2,4-diene acid,
5- (3 ', 5'-ditert-butyl-2'-methoxy-3-biphenylyl) -3-methylpent-2,4-diene acid,
5- (3 ', 5'-ditert-butyl-2'-propoxy-3-biphenylyl) -3-methylpent-2,4-diene acid,
5- (2'-butoxy-3 ', 5'-di-tert-butyl-3-biphenylyl) -3-methylpent-2,4-diene acid,
5- (2'-butoxy-3 ', 5'-di-tert-butyl-6-hydroxy-3-biphenylyl) -3-methylpent-2,4-diene acid,
5- (3 ', 5'-ditert-butyl-6-hydroxy-2'-propoxy-3-biphenylyl) -3-methylpent-2,4-diene acid,
5- (3 ', 5'-ditert-butyl-6-hydroxy-2'-methoxy-3-biphenylyl) -3-methylpent-2,4-diene acid.
R1 представляет радикал -СО-R3,
Ar2 представляет радикал формулы (d) или (е),
R11 представляет радикал -O-R21,
R7 представляет радикал -O-R20.16. Compounds according to claim 1, characterized in that they have at least one and preferably all of the following characteristics:
R 1 represents the radical-CO-R 3 ,
Ar 2 represents a radical of formula (d) or (e),
R 11 represents the radical -OR 21 ,
R 7 represents the radical -OR 20 .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9803976 | 1998-03-31 | ||
FR9803976A FR2776657B1 (en) | 1998-03-31 | 1998-03-31 | BICYCLIC-AROMATIC COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETOLOGY |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99107277A true RU99107277A (en) | 2001-01-27 |
RU2188190C2 RU2188190C2 (en) | 2002-08-27 |
Family
ID=9524691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99107277/04A RU2188190C2 (en) | 1998-03-31 | 1999-03-30 | Bicycle aromatic compounds and composition based on thereof |
Country Status (22)
Country | Link |
---|---|
US (2) | US6632963B1 (en) |
EP (1) | EP0947496B1 (en) |
JP (1) | JP3359882B2 (en) |
KR (1) | KR100288989B1 (en) |
CN (2) | CN1269788C (en) |
AR (1) | AR016458A1 (en) |
AT (1) | ATE225764T1 (en) |
AU (1) | AU724896B2 (en) |
BR (1) | BR9902808A (en) |
CA (1) | CA2264979C (en) |
DE (1) | DE69903368T2 (en) |
DK (1) | DK0947496T3 (en) |
ES (1) | ES2187125T3 (en) |
FR (1) | FR2776657B1 (en) |
HU (1) | HUP9900819A1 (en) |
MX (1) | MXPA99002966A (en) |
NZ (1) | NZ334509A (en) |
PL (1) | PL194066B1 (en) |
PT (1) | PT947496E (en) |
RU (1) | RU2188190C2 (en) |
SG (1) | SG72936A1 (en) |
ZA (1) | ZA991974B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2776657B1 (en) * | 1998-03-31 | 2000-05-26 | Cird Galderma | BICYCLIC-AROMATIC COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETOLOGY |
FR2801305B1 (en) | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | VITAMIN D ANALOGS |
US7053071B2 (en) | 2001-11-30 | 2006-05-30 | The Burnham Institute | Induction of apoptosis in cancer cells |
US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
FR2910321B1 (en) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
FR2910320B1 (en) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
FR2931661B1 (en) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | NOVEL DEPIGMENTING COMPOSITIONS IN THE FORM OF AN ANHYDROUS VASELIN - FREE AND ELASTOMER - FREE COMPOSITION COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE AND A RETINOID. |
EP2755942A2 (en) | 2011-09-15 | 2014-07-23 | Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University | Therapeutic compounds |
JP6476848B2 (en) | 2014-12-26 | 2019-03-06 | ブラザー工業株式会社 | Liquid ejection device |
WO2017197055A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
CN109562113A (en) | 2016-05-10 | 2019-04-02 | C4医药公司 | Loop coil degron body for target protein degradation |
WO2017197046A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | C3-carbon linked glutarimide degronimers for target protein degradation |
US10231947B2 (en) | 2017-01-23 | 2019-03-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Isochroman compounds and methods of use thereof |
US10238626B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
US10238655B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Dihydroindene and tetrahydronaphthalene compounds |
CN109096109B (en) * | 2017-06-21 | 2021-03-30 | 中国石油化工股份有限公司 | Synthesis method of 2-butenoic ester |
JP7247555B2 (en) * | 2018-11-30 | 2023-03-29 | ブラザー工業株式会社 | Piezoelectric actuator and method for manufacturing piezoelectric actuator |
EP3897631A4 (en) | 2018-12-20 | 2022-11-23 | C4 Therapeutics, Inc. | Targeted protein degradation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL49761C (en) | 1936-09-07 | |||
FR2746101B1 (en) * | 1996-03-14 | 1998-04-30 | BICYCLIC-AROMATIC COMPOUNDS | |
FR2752734B1 (en) | 1996-09-02 | 1998-11-06 | Cird Galderma | USE OF RETINOIDS FOR THE PREPARATION OF A MEDICAMENT FOR TREATING CONDITIONS RELATED TO VEGF OVEREXPRESSION |
FR2776657B1 (en) * | 1998-03-31 | 2000-05-26 | Cird Galderma | BICYCLIC-AROMATIC COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETOLOGY |
-
1998
- 1998-03-31 FR FR9803976A patent/FR2776657B1/en not_active Expired - Fee Related
-
1999
- 1999-03-05 AU AU18584/99A patent/AU724896B2/en not_active Ceased
- 1999-03-05 NZ NZ334509A patent/NZ334509A/en unknown
- 1999-03-05 SG SG1999001290A patent/SG72936A1/en unknown
- 1999-03-11 ES ES99400597T patent/ES2187125T3/en not_active Expired - Lifetime
- 1999-03-11 DE DE69903368T patent/DE69903368T2/en not_active Expired - Lifetime
- 1999-03-11 EP EP99400597A patent/EP0947496B1/en not_active Expired - Lifetime
- 1999-03-11 DK DK99400597T patent/DK0947496T3/en active
- 1999-03-11 PT PT99400597T patent/PT947496E/en unknown
- 1999-03-11 ZA ZA9901974A patent/ZA991974B/en unknown
- 1999-03-11 AT AT99400597T patent/ATE225764T1/en active
- 1999-03-25 BR BR9902808-5A patent/BR9902808A/en not_active Application Discontinuation
- 1999-03-26 JP JP08494999A patent/JP3359882B2/en not_active Expired - Fee Related
- 1999-03-29 KR KR1019990010769A patent/KR100288989B1/en not_active IP Right Cessation
- 1999-03-29 AR ARP990101390A patent/AR016458A1/en active IP Right Grant
- 1999-03-29 MX MXPA99002966A patent/MXPA99002966A/en active IP Right Grant
- 1999-03-29 US US09/277,953 patent/US6632963B1/en not_active Expired - Fee Related
- 1999-03-30 PL PL332302A patent/PL194066B1/en unknown
- 1999-03-30 RU RU99107277/04A patent/RU2188190C2/en not_active IP Right Cessation
- 1999-03-30 CA CA002264979A patent/CA2264979C/en not_active Expired - Fee Related
- 1999-03-30 CN CNB991059298A patent/CN1269788C/en not_active Expired - Fee Related
- 1999-03-30 HU HU9900819A patent/HUP9900819A1/en unknown
-
2001
- 2001-09-19 CN CN01140851A patent/CN1346828A/en active Pending
-
2003
- 2003-07-31 US US10/630,872 patent/US6924388B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99107277A (en) | BICYCLIC AROMATIC COMPOUNDS AND THEIR APPLICATION IN MEDICINE AND VETERINARIA, AND ALSO IN COSMETOLOGY | |
RU98109793A (en) | TRIAROMATIC COMPOUNDS CONTAINING THEIR COMPOSITIONS AND THEIR APPLICATION | |
US6368608B1 (en) | Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof | |
JP2753300B2 (en) | Aromatic esters and thioesters | |
RU2003106424A (en) | BIPHENYLIC DERIVATIVES AND THEIR APPLICATION AS ACTIVATORS OF PPARγ RECEPTORS | |
US5597839A (en) | Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics | |
RU2138474C1 (en) | Bicyclic aromatic compounds, pharmaceutical and cosmetic composition | |
RU2121995C1 (en) | Polyene compounds and pharmaceutical and cosmetic compositions based thereon | |
US4876381A (en) | Naphthalene derivatives possessing a retinoid-type action, processes for their preparation, and medicinal and cosmetic compositions containing these derivatives | |
MXPA96005940A (en) | Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization | |
RU2007109778A (en) | NEW BIAROMATIC COMPOUNDS WHICH ACTIVATE PPAR TYPE RECEPTORS AND THEIR APPLICATION IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | |
RU2188190C2 (en) | Bicycle aromatic compounds and composition based on thereof | |
RU2125554C1 (en) | Bi-aromatic acetylene compounds with adamantyl group, pharmaceutical and cosmetic composition based thereon | |
US6825360B1 (en) | Bicyclic aromatic compounds | |
RU2193552C2 (en) | Biphenyl derivatives and pharmaceutical and cosmetic compositions comprising thereof | |
RU99109983A (en) | BIPHENYL DERIVATIVES AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM | |
US5654331A (en) | Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics | |
EP0776881A1 (en) | Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization | |
JP3112469B2 (en) | Diaromatic esters, their preparation and human or veterinary medicine and cosmetic compositions | |
US20070004726A1 (en) | Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors | |
EA001060B1 (en) | Diaromatic propynyl or dienyl compounds, intermediate compounds of pharmacological and cosmetic compositions and usage of cosmetic compositions | |
US6171603B1 (en) | Bioaromatic amido compounds and pharmaceutical/cosmetic compositions comprised thereof | |
RU2005121907A (en) | NEW COMPOUNDS ARE MODULATORS OF RECIPTORS OF TYPE PPARGAMA AND THEIR APPLICATION IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | |
RU2005119990A (en) | NEW BIAROMATIC COMPOUNDS, WHICH ARE ACTIVATORS OF RECEPTORS OF TYPE PPAR GAMMA AND THEIR APPLICATION IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS |